TAM; Peter Y.

Patent Applications and Registrations

Patent applications and USPTO patent grants for TAM; Peter Y..The latest application filed is for "escalating dosing regimen for effecting weight loss and treating obesity".

Company Profile

4.11.31

TAM; Peter Y. - Redwood City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity App 20210379013 - NAJARIAN; Thomas ; et al.	2021-12-09
Low Dose Topiramate/phentermine Composition And Methods Of Use Thereof App 20210378972 - NAJARIAN; Thomas ; et al.	2021-12-09
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity App 20200188352 - NAJARIAN; Thomas ; et al.	2020-06-18
Low Dose Topiramate/phentermine Composition And Methods Of Use Thereof App 20200188313 - NAJARIAN; Thomas ; et al.	2020-06-18
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity App 20190350897 - NAJARIAN; Thomas ; et al.	2019-11-21
Low Dose Topiramate/phentermine Composition And Methods Of Use Thereof App 20190350866 - NAJARIAN; Thomas ; et al.	2019-11-21
Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof App 20170151179 - Najarian; Thomas ; et al.	2017-06-01
Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof App 20160310446 - Najarian; Thomas ; et al.	2016-10-27
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity App 20160250180 - Najarian; Thomas ; et al.	2016-09-01
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity App 20160022630 - Najarian; Thomas ; et al.	2016-01-28
Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors App 20160015730 - Najarian; Thomas ; et al.	2016-01-21
Low Dose Topiramate / Phentermine Composition And Methods Of Use Thereof App 20150313870 - Najarian; Thomas ; et al.	2015-11-05
Treatment Of Obstructive Sleep Apnea Syndrome With A Combination Of A Carbonic Anhydrase Inhibitor And An Additional Active Agent App 20150231110 - Wilson; Leland F. ; et al.	2015-08-20
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity App 20150209325 - Najarian; Thomas ; et al.	2015-07-30
Low dose topiramate/phentermine composition and methods of use thereof Grant 9,011,905 - Najarian , et al. April 21, 2	2015-04-21
Escalating dosing regimen for effecting weight loss and treating obesity Grant 9,011,906 - Najarian , et al. April 21, 2	2015-04-21
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity App 20150010626 - Najarian; Thomas ; et al.	2015-01-08
Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof App 20150010625 - Najarian; Thomas ; et al.	2015-01-08
Escalating dosing regimen for effecting weight loss and treating obesity Grant 8,895,057 - Najarian , et al. November 25, 2	2014-11-25
Low dose topiramate/phentermine composition and methods of use thereof Grant 8,895,058 - Najarian , et al. November 25, 2	2014-11-25
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity App 20140187623 - Najarian; Thomas ; et al.	2014-07-03
Treatment of Obstructive Sleep Apnea Syndrome with a Combination of a Carbonic Anhydrase Inhibitor and an Additional Active Agent App 20140094511 - Wilson; Leland F. ; et al.	2014-04-03
Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors App 20140088162 - Najarian; Thomas ; et al.	2014-03-27
Low Dose Topiramate/Phentermine Composition And Methods Of Use Thereof App 20140037723 - Najarian; Thomas ; et al.	2014-02-06
Low dose topiramate/phentermine composition and methods of use thereof Grant 8,580,298 - Najaraian , et al. November 12, 2	2013-11-12
Escalating dosing regimen for effecting weight loss and treating obesity Grant 8,580,299 - Najarian , et al. November 12, 2	2013-11-12
Treatment of pulmonary hypertension with carbonic anhydrase inhibitors Grant 8,536,138 - Najarian , et al. September 17, 2	2013-09-17
Treatment Of Pulmonary Hypertension With Carbonic Anhydrase Inhibitors App 20120196881 - Najarian; Thomas ; et al.	2012-08-02
Treatment of pulmonary hypertension with carbonic anhydrase inhibitors Grant 8,071,557 - Najarian , et al. December 6, 2	2011-12-06
Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof App 20110262535 - Najarian; Thomas ; et al.	2011-10-27
Low Dose Topiramate / Phentermine Composition And Methods Of Use Thereof App 20100215739 - Najarian; Thomas ; et al.	2010-08-26
Novel Topiramate Compositions And An Escalating Dosing Strategy For Treating Obesity And Related Disorders App 20090304789 - Najarian; Thomas ; et al.	2009-12-10
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity App 20090304785 - Najarian; Thomas ; et al.	2009-12-10
Treatment of pulmonary hypertension with carbonic anhydrase inhibitors App 20080312163 - Najarian; Thomas ; et al.	2008-12-18
Compositions And Methods For Treating Obesity And Related Disorders App 20080255093 - Tam; Peter Y. ; et al.	2008-10-16
Combination Therapy App 20080103179 - Tam; Peter Y. ; et al.	2008-05-01
As-needed administration of an androgenic agent to enhance female desire and responsiveness App 20050070516 - Wilson, Leland F. ; et al.	2005-03-31
As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness App 20030022875 - Wilson, Leland F. ; et al.	2003-01-30
As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness App 20020013304 - Wilson, Leland F. ; et al.	2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.